These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 19157860

  • 1. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
    Mouawad R, Spano JP, Comperat E, Capron F, Khayat D.
    Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
    [Abstract] [Full Text] [Related]

  • 2. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
    Wobser M, Siedel C, Schrama D, Bröcker EB, Becker JC, Vetter-Kauczok CS.
    Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
    Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M.
    Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
    [Abstract] [Full Text] [Related]

  • 4. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H.
    Eur Cytokine Netw; 2003 Nov; 14(3):149-53. PubMed ID: 14656688
    [Abstract] [Full Text] [Related]

  • 5. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B.
    Clin Cancer Res; 2009 Mar 01; 15(5):1741-6. PubMed ID: 19240177
    [Abstract] [Full Text] [Related]

  • 6. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B, Ma J, Wang X, Su F, Li X, Yang S, Ma W, Zhang Y.
    Anat Rec (Hoboken); 2008 Oct 01; 291(10):1227-35. PubMed ID: 18561194
    [Abstract] [Full Text] [Related]

  • 7. An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients.
    Mouawad R, Soubrane C, Rixe O, Khayat D, Spano JP.
    Melanoma Res; 2006 Aug 01; 16(4):335-40. PubMed ID: 16845329
    [Abstract] [Full Text] [Related]

  • 8. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.
    Aktuelle Urol; 2007 Sep 01; 38(5):392-7. PubMed ID: 17907066
    [Abstract] [Full Text] [Related]

  • 9. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 01; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma.
    Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK.
    Clin Cancer Res; 2003 Apr 01; 9(4):1361-9. PubMed ID: 12684405
    [Abstract] [Full Text] [Related]

  • 11. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P, Eming S, Nashan D, Krieg T, Mauch C.
    Br J Dermatol; 2007 Apr 01; 156(4):653-8. PubMed ID: 17263813
    [Abstract] [Full Text] [Related]

  • 12. Novel role for RGS1 in melanoma progression.
    Rangel J, Nosrati M, Leong SP, Haqq C, Miller JR, Sagebiel RW, Kashani-Sabet M.
    Am J Surg Pathol; 2008 Aug 01; 32(8):1207-12. PubMed ID: 18580492
    [Abstract] [Full Text] [Related]

  • 13. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
    Maekawa S, Iwasaki A, Shirakusa T, Enatsu S, Kawakami T, Kuroki M, Kuroki M.
    Anticancer Res; 2007 Aug 01; 27(6A):3735-41. PubMed ID: 17970036
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E, Alexandrou P, Mpakali A, Giannopoulou I, Liapis G, Markaki S, Keramopoulos A, Nakopoulou L.
    Eur J Surg Oncol; 2007 Apr 01; 33(3):294-300. PubMed ID: 17129704
    [Abstract] [Full Text] [Related]

  • 15. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases.
    Bando H, Weich HA, Horiguchi S, Funata N, Ogawa T, Toi M.
    Oncol Rep; 2006 Mar 01; 15(3):653-9. PubMed ID: 16465426
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS.
    Cancer Res; 2008 Jan 15; 68(2):521-9. PubMed ID: 18199548
    [Abstract] [Full Text] [Related]

  • 17. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
    Ricaniadis N, Kataki A, Agnantis N, Androulakis G, Karakousis CP.
    Eur J Surg Oncol; 2001 Feb 15; 27(1):88-93. PubMed ID: 11237497
    [Abstract] [Full Text] [Related]

  • 18. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 15; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR, Min K, Kim HS, Jung WW, Park YK.
    Pathol Res Pract; 2008 Jun 15; 204(8):575-82. PubMed ID: 18440723
    [Abstract] [Full Text] [Related]

  • 20. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.
    Vihinen PP, Hilli J, Vuoristo MS, Syrjänen KJ, Kähäri VM, Pyrhönen SO.
    Acta Oncol; 2007 Jun 15; 46(5):678-84. PubMed ID: 17562445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.